As of the latest Form 4 filed Apr 29, 2026.
What Adicet Bio Inc insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 12 most recent filings for ACET.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-04-29 | 2026-04-27 | RA CAPITAL MANAGEMENT, L.P. 10% owner | JOther | −250K | — | — | No | Form 4 ↗ |
| 2026-04-13 | 2026-02-20 | RA CAPITAL MANAGEMENT, L.P. 10% owner | PPurchase | +74.8K | $7.27 | $543K | No | Form 4 ↗ |
| 2026-04-13 | 2026-02-19 | RA CAPITAL MANAGEMENT, L.P., 10% owner | PPurchase | +74.3K | $7.21 | $535K | No | Form 4 ↗ |
| 2026-04-13 | 2026-02-18 | RA CAPITAL MANAGEMENT, L.P., 10% owner | PPurchase | +74.6K | $7.04 | $525K | No | Form 4 ↗ |
| 2026-04-09 | 2026-04-08 | ORBIMED ADVISORS LLC 10% owner | SSale | −40.4K | $6.52 | $264K | No | Form 4 ↗ |
| 2026-04-09 | 2026-04-08 | ORBIMED ADVISORS LLC, 10% owner | SSale | −32.5K | $6.29 | $205K | No | Form 4 ↗ |
| 2026-04-09 | 2026-04-07 | ORBIMED ADVISORS LLC, 10% owner | SSale | −2.40K | $6.38 | $15.3K | No | Form 4 ↗ |
| 2026-04-09 | 2026-04-07 | ORBIMED ADVISORS LLC, 10% owner | SSale | −29.3K | $6.53 | $191K | No | Form 4 ↗ |
| 2026-01-27 | 2026-01-24 | Aftab Blake Chief Scientific Officer | FTax | −535.00 | $8.44 | $4.52K | No | Form 4 ↗ |
| 2026-01-27 | 2026-01-24 | Healey Don Chief Technology Officer | FTax | −535.00 | $8.44 | $4.52K | No | Form 4 ↗ |
| 2026-01-27 | 2026-01-24 | Schor Chen President & CEO | FTax | −1.75K | $8.44 | $14.8K | No | Form 4 ↗ |
| 2026-01-27 | 2026-01-24 | Harvey Brian Nicholas Chief Financial Officer | FTax | −546.00 | $8.44 | $4.61K | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also ACET’s full analysis or the market-wide insider trading feed. The tabs above jump to ACET’s other SEC data.
Source: SEC Form 4 filings for ACET, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.